Hope in Myeloma: The Road to Long-Term Survival

Cesar Rodriguez, MD In this episode, we sit down with Dr. Cesar Rodriguez of Mount Sinai Hospital in New York, NY to discuss the evolving landscape of myeloma treatment. Groundbreaking innovations are bringing new hope to patients and caregivers. Dr. Rodriguez breaks down the latest advancements in immunotherapy, including CAR T-cell therapy and bispecific antibodies. Hear how researchers and physicians are working to make myeloma into a manageable, long-term disease, while ultimately searching for a cure. DOWNLOAD TRANSCRIPT CLICK HERE to participate in our episode survey. Mentioned on this episode:  Myeloma Monoclonal Gammopathy of Undetermined Significance (MGUS) and Related Conditions Amyloidosis Revised International Staging System (R-ISS) LLS Clinical Trial Support Center Autologous stem cell transplantation Autologous stem cell transplant animated video CAR T-cell therapy Bispecific antibodies – Immunotherapy fact sheet Additional LLS Support Resources:  Free Nutrition Consultations Information Specialists  Financial support Free telephone/web patient programs  Free booklets  Young Adult Resources Online chats  Support groups  Caregiver support  Caregiver Workbook Advocacy and Public Policy Survivorship Workbook LLS Community  Mental Health Resources Supported by Abbvie Inc.; Genentech, A Member of the Roche Group; and Johnson & Johnson.The post Hope in Myeloma: The Road to Long-Term Survival first appeared on The Bloodline with Blood Cancer United Podcast.